Quarterly report pursuant to Section 13 or 15(d)

Equity (Summary Of Non-Vested Restricted Stock And Restricted Stock Units) (Details)

v3.22.1
Equity (Summary Of Non-Vested Restricted Stock And Restricted Stock Units) (Details) - Restricted Stock [Member]
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Non-vested Restricted Stock, Beginning Balance 460,470
Non-vested Restricted Stock, Granted 208,035
Non-vested Restricted Stock, Ending Balance 668,505
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 20.72
Weighted Average Grant Date Fair Value, Granted | $ / shares 29.80
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 23.55
Available for grant 1,331,495